NURS 2080 Exam 4
acid rebound - ANS condition in which the stomach increases acid release in response to low acid
(high pH); this can occur in response to using antacids that decrease acid
antacids - ANS group of inorganic chemicals that neutralize stomach acid
digestive enzymes - ANS enzymes produced in the gastrointestinal tract to break down foods into
usable nutrients
gastroesophageal reflux disease (GERD) - ANS backward movement of gastric contents into the
esophagus that causes mucosal lining damage and/or heartburn symptoms
gastrointestinal protectant - ANS drug that coats any injured area in the stomach to prevent further
injury from acid or pepsin
histamine-2 (H2) antagonist - ANS drug that blocks the H2 receptor sites; used to decrease acid
production in the stomach (H2 sites are stimulated to cause the release of acid in response to gastrin
or parasympathetic stimulation)
peptic ulcer - ANS erosion of the lining of the stomach or duodenum
prostaglandin - ANS any one of numerous tissue hormones that have local effects on various systems
and orgANS of the body, including vasoconstriction, vasodilation, increased or decreased GI activity,
and increased or decreased pancreatic enzyme release
proton pump inhibitor - ANS drug that blocks the H+, K+-ATPase enzyme system on the secretory
surface of the gastric parietal cells, thus interfering with the final step of acid production and
lowering acid levels in the stomach
they selectively block specific histamine receptor sites, leading to a reduction in gastric acid
secretion - ANS which would a nurse include when describing the action of H2 antagonist to a
patient
heart, CNS, and stomach - ANS H2 receptors are found throughout the body, including in the
,heartburn - ANS a patient has been taking an H2 antagonist. which symptom would the nurse expect
to be relieved if the medication was effective
gastric cancer - ANS which of the following has not been considered a risk of taking proton pump
inhibitors for long duration
lowering gastric acid to an alkaline level simulates the release of gastric acid - ANS acid rebound is a
condition that occurs when
swallow tablets or capsules whole - ANS a nurse taking care of a patient who is receiving a proton
pump inhibitor should teach the patient to
prevent NSAID related gastric ulcers in patients at high risk - ANS Misoprostol (Cytotec) is a
prostaglandin that is used to
signs of GI irritation - ANS a nurse caring for a patient receiving pancreatic enzymes as replacement
therapy should be assessing the patient for
systemic alkalosis
electrolyte imbalance
hypokalemia
constipation or diarrhea
muscular weakness - ANS patients who use antacids frequently can be expected to experience which
adverse effects
cancer radiation therapy
stroke
brain injury - ANS Saliva substitute (Moi-Stir) may be useful in which circumstances
false - ANS T/F
Misoprostol (Cytotec) is given to pregnant women with gastric reflex because it increases
bicarbonate and mucous production to protect the stomach with minimal systemic effects.
, hydrochloric acid, gastrin - ANS Histamine 2 (H2) antagonists block the release of ___ in response to
___
false - ANS T/F
Cimetidine (Tagamet) is recommended for the treatment of peptic ulcer ad gastroesophageal reflux
in children under 16 years of age.
true - ANS T/F
Calcium carbonate (Tums) is, in reality, precipitated chalk.
peptic ulcers - ANS Erosions in the lining of GI tract and stomach are called
sucralfate - ANS is designed for short-term treatment of duodenal ulcers by forming an ulcer-
adherent complex coating at the eroded ulcer sites in the GI system, which protects the sites against
acid, pepsin, and bile salts
false - ANS T/F
antacids are organic compounds that have long been safely used with very few adverse effects and
are tolerated by most people.
true - ANS T/F
antacids can profoundly affect the absorption of many drugs, so patient teaching should include the
information that antacids should be taken 2 hours before or after other medications.
proton pump inhibitor - ANS Lansoprazole (Prevacid) is an example of a(n) ___, which is designed to
suppress gastric acid secretion by inhibiting the hydrogen-potassium adenosine triphosphates
acid rebound - ANS misuse of over the counter antacids can lead to ___, which results from the
stomach's attempt to maintain normal acid levels
acid rebound - ANS condition in which the stomach increases acid release in response to low acid
(high pH); this can occur in response to using antacids that decrease acid
antacids - ANS group of inorganic chemicals that neutralize stomach acid
digestive enzymes - ANS enzymes produced in the gastrointestinal tract to break down foods into
usable nutrients
gastroesophageal reflux disease (GERD) - ANS backward movement of gastric contents into the
esophagus that causes mucosal lining damage and/or heartburn symptoms
gastrointestinal protectant - ANS drug that coats any injured area in the stomach to prevent further
injury from acid or pepsin
histamine-2 (H2) antagonist - ANS drug that blocks the H2 receptor sites; used to decrease acid
production in the stomach (H2 sites are stimulated to cause the release of acid in response to gastrin
or parasympathetic stimulation)
peptic ulcer - ANS erosion of the lining of the stomach or duodenum
prostaglandin - ANS any one of numerous tissue hormones that have local effects on various systems
and orgANS of the body, including vasoconstriction, vasodilation, increased or decreased GI activity,
and increased or decreased pancreatic enzyme release
proton pump inhibitor - ANS drug that blocks the H+, K+-ATPase enzyme system on the secretory
surface of the gastric parietal cells, thus interfering with the final step of acid production and
lowering acid levels in the stomach
they selectively block specific histamine receptor sites, leading to a reduction in gastric acid
secretion - ANS which would a nurse include when describing the action of H2 antagonist to a
patient
heart, CNS, and stomach - ANS H2 receptors are found throughout the body, including in the
,heartburn - ANS a patient has been taking an H2 antagonist. which symptom would the nurse expect
to be relieved if the medication was effective
gastric cancer - ANS which of the following has not been considered a risk of taking proton pump
inhibitors for long duration
lowering gastric acid to an alkaline level simulates the release of gastric acid - ANS acid rebound is a
condition that occurs when
swallow tablets or capsules whole - ANS a nurse taking care of a patient who is receiving a proton
pump inhibitor should teach the patient to
prevent NSAID related gastric ulcers in patients at high risk - ANS Misoprostol (Cytotec) is a
prostaglandin that is used to
signs of GI irritation - ANS a nurse caring for a patient receiving pancreatic enzymes as replacement
therapy should be assessing the patient for
systemic alkalosis
electrolyte imbalance
hypokalemia
constipation or diarrhea
muscular weakness - ANS patients who use antacids frequently can be expected to experience which
adverse effects
cancer radiation therapy
stroke
brain injury - ANS Saliva substitute (Moi-Stir) may be useful in which circumstances
false - ANS T/F
Misoprostol (Cytotec) is given to pregnant women with gastric reflex because it increases
bicarbonate and mucous production to protect the stomach with minimal systemic effects.
, hydrochloric acid, gastrin - ANS Histamine 2 (H2) antagonists block the release of ___ in response to
___
false - ANS T/F
Cimetidine (Tagamet) is recommended for the treatment of peptic ulcer ad gastroesophageal reflux
in children under 16 years of age.
true - ANS T/F
Calcium carbonate (Tums) is, in reality, precipitated chalk.
peptic ulcers - ANS Erosions in the lining of GI tract and stomach are called
sucralfate - ANS is designed for short-term treatment of duodenal ulcers by forming an ulcer-
adherent complex coating at the eroded ulcer sites in the GI system, which protects the sites against
acid, pepsin, and bile salts
false - ANS T/F
antacids are organic compounds that have long been safely used with very few adverse effects and
are tolerated by most people.
true - ANS T/F
antacids can profoundly affect the absorption of many drugs, so patient teaching should include the
information that antacids should be taken 2 hours before or after other medications.
proton pump inhibitor - ANS Lansoprazole (Prevacid) is an example of a(n) ___, which is designed to
suppress gastric acid secretion by inhibiting the hydrogen-potassium adenosine triphosphates
acid rebound - ANS misuse of over the counter antacids can lead to ___, which results from the
stomach's attempt to maintain normal acid levels
